DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Management is scheduled ...

Fintel reports that on January 7, 2025, Evercore ISI Group downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from ...

DENTSPLY SIRONA (XRAY – Research Report) received a Hold rating and price target from Evercore ISI analyst Elizabeth Anderson CFA today. The ...

Everence Capital Management Inc. acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the 4th quarter, ...

Evercore ISI downgraded Dentsply Sirona (XRAY) to In Line from Outperform with a $20 price target The firm is moving to the sidelines as it ...

Mizuho has recently initiated DENTSPLY SIRONA Inc (XRAY) stock to Neutral rating, as announced on December 4, 2024, according to Finviz. Earlier, on November 7, 2024, Leerink Partners had reduced the ...

The complaints allege that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to ...

Detailed price information for Dentsply Sirona Inc (XRAY-Q) from The Globe and Mail including charting and trades.

You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected].

NDAQ:XRAY) Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Dentsply Sirona Inc. (XRAY) Shareholders ...

The complaints allege that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) DENTSPLY targeted low-income people who did not have ...

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $19.16 which represents a slight increase of $0.26 or 1.38% from the prior close of $18.9. The stock opened at $18.79 and ...